Transcriptomic analysis also revealed a positive correlation between patient GBM expression of EDA and aggregate expression of MES subtype genes CHI3LI, TIMP1, and SPOCD1 that confer a worse prognosis (P = 0.0012; Figure 5B) (43). The gene discussed is EDA; the disease is glioblastoma.